Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.87

Daily Change: -$0.05 / 2.67%

Daily Range: $1.79 - $1.92

Market Cap: $1,200,107,904

Daily Volume: 25,231,717

Performance Metrics

1 Week: 15.34%

1 Month: 40.30%

3 Months: 69.37%

6 Months: 35.25%

1 Year: -28.52%

YTD: 42.42%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country:

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

ADMA Biologics Inc (ADMA)

SI-BONE, Inc. (SIBN)

KORU Medical Systems, Inc. (KRMD)